Issue 8/2018
Content (18 Articles)
Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis
P. D. Delgado-López, E. Riñones-Mena, E. M. Corrales-García
Top ten errors of statistical analysis in observational studies for cancer research
A. Carmona-Bayonas, P. Jimenez-Fonseca, A. Fernández-Somoano, F. Álvarez-Manceñido, E. Castañón, A. Custodio, F. A. de la Peña, R. M. Payo, L. P. Valiente
Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients
A. Mitsuhashi, Y. Okuma
Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics
R. Yahyapour, E. Motevaseli, A. Rezaeyan, H. Abdollahi, B. Farhood, M. Cheki, S. Rezapoor, D. Shabeeb, A. E. Musa, M. Najafi, V. Villa
From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence
A. Zygogianni, M. Protopapa, A. Kougioumtzopoulou, F. Simopoulou, S. Nikoloudi, V. Kouloulias
Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy
S. García-Barreras, F. Rozet, I. Nunes-Silva, V. Srougi, R. Sanchez-Salas, E. Barret, M. Galiano, X. Cathelineau
Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma
J. Lee, S. H. Kang, O. K. Noh, M. Chun, Y.-T. Oh, B.-W. Kim, S.-W. Kim
Oncological strategies for locally advanced rectal cancer with synchronous liver metastases, interval strategy versus rectum first strategy: a comparison of short-term outcomes
H. Salvador-Rosés, S. López-Ben, M. Casellas-Robert, P. Planellas, N. Gómez-Romeu, R. Farrés, E. Ramos, A. Codina-Cazador, J. Figueras
A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making
L. Ye, F. Xu, S. Shi, Z. Zeng, X. Jin, Y. Huang, C. Lu, J. Gu, D. Ge, J. He
CXCL12 gene silencing down-regulates metastatic potential via blockage of MAPK/PI3K/AP-1 signaling pathway in colon cancer
J. Ma, H. Su, B. Yu, T. Guo, Z. Gong, J. Qi, X. Zhao, J. Du
Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net project
A. Juan Ribelles, P. Berlanga, G. Schreier, M. Nitzlnader, B. Brunmair, V. Castel, S. Essiaf, A. Cañete, R. Ladenstein
Association of urinary and plasma DNA in early breast cancer patients and its links to disease relapse
Z. Liu, W. Liu
A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain
Jesús García-Mata, Cecilio Álamo, Javier de Castro, Jorge Contreras, Rafael Gálvez, Carlos Jara, Antonio Llombart, Concepción Pérez, Pedro Sánchez, Susana Traseira, Juan-Jesús Cruz
Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients
J. Garde-Noguera, P. Martin-Martorell, M. De Julián, J. Perez-Altozano, C. Salvador-Coloma, J. García-Sanchez, A. Insa-Molla, M. Martín, X. Mielgo-Rubio, S. Marin-Liebana, A. Blasco-Cordellat, S. Blasco-Molla, R. Gironés, D. Marquez-Medina, F. Aparisi, M. C. Bas Cerda, S. Macia-Escalante, A. Sánchez, O. Juan-Vidal
Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma
J. Jiang, M. He, X. Hu, C. Ni, L. Yang
Geriatric oncology in Spain: survey results and analysis of the current situation
R. Gironés, I. Morilla, C. Guillen-Ponce, M. D. Torregrosa, I. Paredero, E. Bustamante, S. del Barco, G. Soler, B. Losada, L. Visa, E. Llabrés, B. Fox, J. L. Firvida, R. Blanco, M. Antonio, F. Aparisi, M. Pi-Figueras, E. Gonzalez-Flores, M. J. Molina-Garrido, J. Saldaña
Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology
R. Colomer, I. Aranda-López, J. Albanell, T. García-Caballero, E. Ciruelos, M. Á. López-García, J. Cortés, F. Rojo, M. Martín, J. Palacios-Calvo
Correction to: Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients
J. Garde-Noguera, P. Martin-Martorell, M. De Julián, J. Perez-Altozano, C. Salvador-Coloma, J. García-Sanchez, A. Insa-Molla, M. Martín, X. Mielgo-Rubio, S. Marin-Liebana, A. Blasco-Cordellat, S. Blasco-Molla, R. Gironés, D. Marquez-Medina, F. Aparisi, M. C. Bas Cerda, S. Macia-Escalante, A. Sánchez, O. Juan-Vidal